Predictions
Astrazeneca ADR
Start price
Target price
Perf. (%)
€41.60
17.12.20
17.12.20
€48.00
17.12.21
17.12.21
9.86%
03.06.21
03.06.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.91
17.12.20
17.12.20
€29.00
-1.81%
21.12.20
21.12.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Jaguar Health Inc.
Start price
Target price
Perf. (%)
€61.20
14.12.20
14.12.20
€225.00
1282.35%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€3.06
13.12.20
13.12.20
-
13.12.21
13.12.21
1.50%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Ionis Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.79
13.12.20
13.12.20
-
13.12.21
13.12.21
-29.55%
14.12.21
14.12.21
Risky Investment
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€142.00
13.12.20
13.12.20
€170.00
13.12.21
13.12.21
9.00%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Curis Inc.
Start price
Target price
Perf. (%)
€6.35
13.12.20
13.12.20
-
13.12.21
13.12.21
37.01%
16.02.21
16.02.21
Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.66
13.12.20
13.12.20
-
13.12.21
13.12.21
143.95%
16.02.21
16.02.21
Probably not worthwhile Investment
Significant cyclical dependencies
PhaseBio Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.60
12.12.20
12.12.20
-
12.12.21
12.12.21
-42.22%
13.12.21
13.12.21
Probably not worthwhile Investment
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€395.05
12.12.20
12.12.20
-
12.12.21
12.12.21
4.78%
09.01.21
09.01.21
Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Formycon AG
Start price
Target price
Perf. (%)
€65.20
12.12.20
12.12.20
-
12.12.21
12.12.21
-7.06%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€35.01
12.12.20
12.12.20
-
12.12.21
12.12.21
-14.23%
24.03.21
24.03.21
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
vTv Therapeutics Inc
Start price
Target price
Perf. (%)
€2.30
12.12.20
12.12.20
€1.00
12.12.21
12.12.21
-14.22%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€3.78
12.12.20
12.12.20
€2.00
12.12.21
12.12.21
4.76%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€392.75
11.12.20
11.12.20
€250.00
0.97%
11.12.20
11.12.20
Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Inovio Pharma
Start price
Target price
Perf. (%)
€9.35
10.12.20
10.12.20
€7.00
10.12.21
10.12.21
20.86%
20.02.21
20.02.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Immutep LTD ADR
Start price
Target price
Perf. (%)
€5.85
10.12.20
10.12.20
€5.00
-20.34%
10.12.20
10.12.20
Could be very worthwhile Investment >20% year
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.56
08.12.20
08.12.20
-
6.64%
10.12.20
10.12.20
Risky Investment
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.51
07.12.20
07.12.20
€25.00
07.12.21
07.12.21
93.92%
08.12.21
08.12.21
Could be very worthwhile Investment >20% year
Trevena Inc.
Start price
Target price
Perf. (%)
€49.08
04.12.20
04.12.20
€55.00
28.04.21
28.04.21
23.84%
09.02.21
09.02.21
Could be very worthwhile Investment >20% year